Metabolic and cardiovascular risks of hormone treatment for transgender individuals
NL de Silva, A Dimakopoulou, O Quinton… - Best Practice & …, 2024 - Elsevier
Identifying metabolic and cardiovascular risks of gender-affirming hormone therapy (GAHT)
is challenging due to other confounding variables that affect patient outcomes and the …
is challenging due to other confounding variables that affect patient outcomes and the …
Considerations for the care of transgender patients in orthopaedics and sports medicine: a narrative review
M Hayes-Lattin, LM Krivicich, JT Bragg… - British Journal of …, 2024 - bjsm.bmj.com
Orthopaedic and sports medicine clinicians can improve outcomes for transgender patients
by understanding the physiological effects of gender-affirming hormone therapy (GAHT) …
by understanding the physiological effects of gender-affirming hormone therapy (GAHT) …
Comparison of Estrone/Estradiol Ratio and Levels in Transfeminine Individuals on Different Routes of Estradiol
Purpose: Estradiol for gender-affirming hormone therapy can be taken in different routes:
oral, sublingual, transdermal patch or gel, and injectable estradiol. We aimed at comparing …
oral, sublingual, transdermal patch or gel, and injectable estradiol. We aimed at comparing …
Association between serum estradiol and cardiovascular health among transgender adults using gender-affirming estrogen therapy
Gender-affirming estrogen therapy (GAET) is commonly used for feminization in transgender
and nonbinary (TNB) individuals, yet the optimal rate of change (ROC) in estradiol levels for …
and nonbinary (TNB) individuals, yet the optimal rate of change (ROC) in estradiol levels for …
Considerations for Gender‐Affirming Hormonal and Surgical Care Among Transgender and Gender Diverse Adolescents and Adults With Congenital Heart Disease
DJ Harrison, F Prada, NJ Nokoff… - Journal of the …, 2024 - Am Heart Assoc
Background Transgender and gender diverse (TGD) individuals and long‐term survivors
with adult congenital heart disease (ACHD) are both growing populations with specialized …
with adult congenital heart disease (ACHD) are both growing populations with specialized …
Thrombotic Risk Associated with Gender-Affirming Hormone Therapy
TLK Mullins, ES Mullins - Journal of Thrombosis and Haemostasis, 2024 - Elsevier
Transgender and gender-expansive (TG) people–those who identify with a gender other
than their assigned sex at birth–frequently experience gender dysphoria, which is …
than their assigned sex at birth–frequently experience gender dysphoria, which is …
Medical Care for Transgender and Gender-Diverse People
J Abramowitz, N Agrawal - Care of Adults with Chronic Childhood …, 2024 - Springer
Transgender and gender-diverse (TGD) patients have unique healthcare needs that have
historically been unmet due to a paucity of gender-affirming providers knowledgeable in …
historically been unmet due to a paucity of gender-affirming providers knowledgeable in …
Gender Transition: A Consideration for Anesthesia
S Pajek, SD Verling, T Smaka - A Comprehensive Guide to Male Aesthetic …, 2024 - Springer
Clinicians have long lacked guidance on how to appropriately manage transgender patients
perioperatively. This chapter aims to provide guidance on the safe management of …
perioperatively. This chapter aims to provide guidance on the safe management of …
[PDF][PDF] The Cardiovascular Implications of Gender-Affirming Estrogen Therapy Use in Transgender Women
CL Rytz - 2024 - prism.ucalgary.ca
The Cardiovascular Implications of Gender-Affirming Estrogen Therapy Use in Transgender
Women Page 1 University of Calgary PRISM Repository https://prism.ucalgary.ca The Vault …
Women Page 1 University of Calgary PRISM Repository https://prism.ucalgary.ca The Vault …